UG

Urmila Gandhi

Active Director Director DIN 02631478
DIN 02631478 First appointment Apr 2005 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2005
Shareholding value •••• Premium profile

About Urmila Gandhi

Data last updated:

Urmila Gandhi is a Director at U.S. Labco Private Limited (since 2005). The company operates in Pharma. U.S. Labco Private Limited reported revenue of ₹8.89 Cr (FY 2025).

DIN 02631478
Primary Designation Director
Industry Pharma
First Appointment 15 Apr 2005
Oldest Company Age 21 yrs
Largest company U.S. Labco Private Limited · ₹8.89 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
U.S. Labco Private Limited U02423MP2005PTC017523
Director15 Apr 20052005₹8.89 Cr (FY 2025)Active

Board colleagues of Urmila Gandhi

Directorship timeline

Open interactive timeline →
U.S. Labco Private Limited
Premium access

Shareholding and investment profile for Urmila Gandhi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Urmila Gandhi

Urmila Gandhi currently holds 1 directorship: U.S. Labco Private Limited (Director, since 15 Apr 2005, revenue ₹8.89 Cr (FY 2025)).

Urmila Gandhi was first appointed on 15 Apr 2005 as Director at U.S. Labco Private Limited.

The current boards of Urmila Gandhi's companies include Ashutosh Gandhi (U.S. Labco Private Limited), Poonam Gandhi (U.S. Labco Private Limited), Ramesh Chand Gandhi (U.S. Labco Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available